190 related articles for article (PubMed ID: 23761177)
1. Chick embryo extract demethylates tumor suppressor genes in osteosarcoma cells.
Mu X; Sultankulov B; Agarwal R; Mahjoub A; Schott T; Greco N; Huard J; Weiss K
Clin Orthop Relat Res; 2014 Mar; 472(3):865-73. PubMed ID: 23761177
[TBL] [Abstract][Full Text] [Related]
2. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
3. The HDAC inhibitor Vorinostat diminishes the in vitro metastatic behavior of Osteosarcoma cells.
Mu X; Brynien D; Weiss KR
Biomed Res Int; 2015; 2015():290368. PubMed ID: 25785263
[TBL] [Abstract][Full Text] [Related]
4. S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications.
Parashar S; Cheishvili D; Arakelian A; Hussain Z; Tanvir I; Khan HA; Szyf M; Rabbani SA
Cancer Med; 2015 May; 4(5):732-44. PubMed ID: 25619880
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic reprogramming underlies efficacy of DNA demethylation therapy in osteosarcomas.
Asano N; Takeshima H; Yamashita S; Takamatsu H; Hattori N; Kubo T; Yoshida A; Kobayashi E; Nakayama R; Matsumoto M; Nakamura M; Ichikawa H; Kawai A; Kondo T; Ushijima T
Sci Rep; 2019 Dec; 9(1):20360. PubMed ID: 31889115
[TBL] [Abstract][Full Text] [Related]
6. Specific reversal of tumor-suppressor gene promoter hypermethylation with bovine oocyte extract.
Wang Z; Gao H; Wang H; Ren X; Bao L; Sa R; Wang J; Bai H; Yu H
Oncol Rep; 2013 Jul; 30(1):179-84. PubMed ID: 23670097
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of AP-1 transcriptional activity blocks the migration, invasion, and experimental metastasis of murine osteosarcoma.
Leaner VD; Chick JF; Donninger H; Linniola I; Mendoza A; Khanna C; Birrer MJ
Am J Pathol; 2009 Jan; 174(1):265-75. PubMed ID: 19074613
[TBL] [Abstract][Full Text] [Related]
8. Metastasis-associated differences in gene expression in a murine model of osteosarcoma.
Khanna C; Khan J; Nguyen P; Prehn J; Caylor J; Yeung C; Trepel J; Meltzer P; Helman L
Cancer Res; 2001 May; 61(9):3750-9. PubMed ID: 11325848
[TBL] [Abstract][Full Text] [Related]
9. High SENP3 Expression Promotes Cell Migration, Invasion, and Proliferation by Modulating DNA Methylation of E-Cadherin in Osteosarcoma.
Yang P; Liu Y; Qi YC; Lian ZH
Technol Cancer Res Treat; 2020; 19():1533033820956988. PubMed ID: 33030103
[TBL] [Abstract][Full Text] [Related]
10. IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling.
Lu J; Song G; Tang Q; Zou C; Han F; Zhao Z; Yong B; Yin J; Xu H; Xie X; Kang T; Lam Y; Yang H; Shen J; Wang J
J Clin Invest; 2015 May; 125(5):1839-56. PubMed ID: 25822025
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the metastatic phenotype of a panel of established osteosarcoma cells.
Ren L; Mendoza A; Zhu J; Briggs JW; Halsey C; Hong ES; Burkett SS; Morrow J; Lizardo MM; Osborne T; Li SQ; Luu HH; Meltzer P; Khanna C
Oncotarget; 2015 Oct; 6(30):29469-81. PubMed ID: 26320182
[TBL] [Abstract][Full Text] [Related]
12. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic reprogramming of human lung cancer cells with the extract of bovine parthenogenetic oocytes.
Wang Z; Dao R; Bao L; Dong Y; Wang H; Han P; Yue Y; Yu H
J Cell Mol Med; 2014 Sep; 18(9):1807-15. PubMed ID: 24889513
[TBL] [Abstract][Full Text] [Related]
14. A novel interplay between HOTAIR and DNA methylation in osteosarcoma cells indicates a new therapeutic strategy.
Li X; Lu H; Fan G; He M; Sun Y; Xu K; Shi F
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2189-2200. PubMed ID: 28730284
[TBL] [Abstract][Full Text] [Related]
15. TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma.
Itoh H; Kadomatsu T; Tanoue H; Yugami M; Miyata K; Endo M; Morinaga J; Kobayashi E; Miyamoto T; Kurahashi R; Terada K; Mizuta H; Oike Y
Oncogene; 2018 May; 37(22):2903-2920. PubMed ID: 29515232
[TBL] [Abstract][Full Text] [Related]
16. Slit-Robo GTPase-Activating Protein 2 as a metastasis suppressor in osteosarcoma.
Marko TA; Shamsan GA; Edwards EN; Hazelton PE; Rathe SK; Cornax I; Overn PR; Varshney J; Diessner BJ; Moriarity BS; O'Sullivan MG; Odde DJ; Largaespada DA
Sci Rep; 2016 Dec; 6():39059. PubMed ID: 27966608
[TBL] [Abstract][Full Text] [Related]
17. Zebularine enhances apoptosis of human osteosarcoma cells by suppressing methylation of ARHI.
Ye K; Wang S; Wang J; Han H; Ma B; Yang Y
Cancer Sci; 2016 Dec; 107(12):1851-1857. PubMed ID: 27685841
[TBL] [Abstract][Full Text] [Related]
18. Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential.
Techavichit P; Gao Y; Kurenbekova L; Shuck R; Donehower LA; Yustein JT
BMC Cancer; 2016 Nov; 16(1):869. PubMed ID: 27821163
[TBL] [Abstract][Full Text] [Related]
19. Low-dose DNA demethylating therapy induces reprogramming of diverse cancer-related pathways at the single-cell level.
Takeshima H; Yoda Y; Wakabayashi M; Hattori N; Yamashita S; Ushijima T
Clin Epigenetics; 2020 Sep; 12(1):142. PubMed ID: 32958049
[TBL] [Abstract][Full Text] [Related]
20. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
